The insulin receptor substrate-1: A biomarker for cancer?
- 1 March 2009
- journal article
- review article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 315 (5), 727-732
- https://doi.org/10.1016/j.yexcr.2008.09.017
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistanceBreast Cancer Research and Treatment, 2007
- The insulin-like growth factor-I receptor as a target for cancer therapyEmerging Therapeutic Targets, 2005
- A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenograftsInternational Journal of Cancer, 2004
- Regulation of IGF-I Receptor Signaling in Tumor CellsHormone and Metabolic Research, 2003
- The IGF‐1 receptor in cancer biologyInternational Journal of Cancer, 2003
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- The Constitutively Active Mutant Gα13Transforms Mouse Fibroblast Cells Deficient in Insulin-like Growth Factor-I ReceptorPublished by Elsevier BV ,1997
- Insulin-Like Growth Factor I Receptor Signaling in Transformation by src OncogenesMolecular and Cellular Biology, 1997
- A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor.Molecular and Cellular Biology, 1994
- Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.Proceedings of the National Academy of Sciences, 1993